Highlights from this issue
Further evidence supporting programmatic screening for, and treatment of latent TB Infection (LTBI) in new entrants to the UK from high TB prevalence countries
The association of diabetes and tuberculosis
Tuberculosis immunodiagnosis
Risk of tuberculosis following HIV seroconversion in high-income countries
Association of diabetes and tuberculosis
Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype
Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing
Single-step QuantiFERON screening of adult contacts
Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
New treatments for Tuberculosis
Lower prevalence of tuberculosis infection in BCG vaccinees
BCG-specific IgG-secreting peripheral plasmablasts as a potential biomarker of active tuberculosis in HIV negative and HIV positive patients
Review of the British Thoracic Society Winter Meeting 2012, 5 to 7 December, London, UK
Advances in tuberculosis 2011–2012
BCG protects against tuberculosis irrespective of HIV status
The yield of different pleural fluid volumes for Mycobacterium tuberculosis culture
Follow-up of the Finnish Asthma Programme 2000–2010
FEV1 decline in cystic fibrosis
Author's response
Primary lysis/necrosis of eosinophils and clinical control of asthma
Authors’ response
Amoxycillin-clavulanate for chronic wet cough in children
Letter in response to
How should I interpret an interferon gamma release assay result for tuberculosis infection?
A case of cough and breathlessness
A cavitating pulmonary lesion with eosinophilia
Rapid-growth pneumatocele mimics massive pneumothorax in a HIV-positive patient